Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 10 studies | 30% ± 15% | |
adipocyte | 9 studies | 42% ± 15% | |
oligodendrocyte precursor cell | 9 studies | 29% ± 9% | |
fibroblast | 8 studies | 36% ± 14% | |
oligodendrocyte | 7 studies | 27% ± 12% | |
astrocyte | 6 studies | 30% ± 18% | |
ciliated cell | 5 studies | 23% ± 4% | |
GABAergic neuron | 4 studies | 29% ± 12% | |
endothelial cell | 3 studies | 39% ± 14% | |
extravillous trophoblast | 3 studies | 69% ± 7% | |
glutamatergic neuron | 3 studies | 30% ± 6% | |
connective tissue cell | 3 studies | 47% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 98% | 1695.58 | 452 / 459 | 94% | 42.28 | 1054 / 1118 |
lung | 85% | 383.13 | 491 / 578 | 72% | 12.77 | 827 / 1155 |
bladder | 90% | 867.86 | 19 / 21 | 56% | 9.36 | 281 / 504 |
ovary | 97% | 2293.15 | 174 / 180 | 45% | 8.02 | 194 / 430 |
skin | 60% | 2561.32 | 1080 / 1809 | 73% | 14.47 | 345 / 472 |
brain | 78% | 259.59 | 2053 / 2642 | 31% | 4.93 | 218 / 705 |
kidney | 75% | 274.65 | 67 / 89 | 26% | 3.42 | 233 / 901 |
adipose | 99% | 1629.93 | 1197 / 1204 | 0% | 0 | 0 / 0 |
uterus | 39% | 426.68 | 66 / 170 | 51% | 9.84 | 233 / 459 |
esophagus | 22% | 45.51 | 323 / 1445 | 64% | 13.54 | 118 / 183 |
pancreas | 8% | 24.04 | 25 / 328 | 75% | 14.99 | 133 / 178 |
intestine | 33% | 99.69 | 321 / 966 | 46% | 7.63 | 241 / 527 |
eye | 0% | 0 | 0 / 0 | 79% | 11.59 | 63 / 80 |
tonsil | 0% | 0 | 0 / 0 | 69% | 15.16 | 31 / 45 |
stomach | 9% | 19.42 | 32 / 359 | 52% | 8.33 | 149 / 286 |
thymus | 45% | 104.07 | 291 / 653 | 16% | 2.32 | 98 / 605 |
spleen | 52% | 109.18 | 126 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 41% | 3.94 | 12 / 29 |
prostate | 40% | 114.13 | 97 / 245 | 1% | 0.11 | 6 / 502 |
blood vessel | 40% | 148.18 | 533 / 1335 | 0% | 0 | 0 / 0 |
heart | 34% | 137.02 | 289 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 6% | 13.19 | 16 / 258 | 16% | 1.43 | 37 / 230 |
liver | 5% | 12.58 | 12 / 226 | 7% | 0.77 | 27 / 406 |
muscle | 6% | 19.98 | 49 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 4% | 5.76 | 35 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007520 | Biological process | myoblast fusion |
GO_0007155 | Biological process | cell adhesion |
GO_0006508 | Biological process | proteolysis |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | ADAM12 |
Protein name | ADAM metallopeptidase domain 12 (Metalloprotease-disintegrin 12 transmembrane isoform La) Disintegrin and metalloproteinase domain-containing protein 12 (ADAM 12) (EC 3.4.24.-) (Meltrin-alpha) |
Synonyms | MLTN UNQ346/PRO545 |
Description | FUNCTION: Involved in skeletal muscle regeneration, specifically at the onset of cell fusion. Also involved in macrophage-derived giant cells (MGC) and osteoclast formation from mononuclear precursors (By similarity). . |
Accessions | ENST00000368676.8 [O43184-2] Q5JRP2 O43184 ENST00000368679.8 [O43184-1] ENST00000448723.2 |